Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease

Lignende værker

• Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
  af: Fujihara, Kazuya, et al.
  Udgivet: (2015)
• Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation
  af: Estruch, Montserrat, et al.
  Udgivet: (2013)
• Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
  af: Palinski, W, et al.
  Udgivet: (1995)
• Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL
  af: Kyrklund, Mikael, et al.
  Udgivet: (2020)
• Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine(1)
  af: Gonen, Ayelet, et al.
  Udgivet: (2014)